The Board of Directors of Pharmiva has appointed Anna Linton as their new Chief Executive Officer.
Anna Linton is currently the CEO of UniMedic and she will join Pharmiva on August 8th.
Christina Östberg Lloyd is resigning as CEO of Pharmiva on April 30th to take on another role outside of the company but she will remain as medical advisor to the company. Vice president Karoline Akerjordet will become acting CEO from May 1st until Linton takes office in August.
Anna Linton has more than 20 years of experience from the pharmaceutical industry, and before joining UniMedic she has been the Nordic CEO of Recordati and Grünenthal. She has also held leading positions within commercialization and sales at Abbott, Wyeth and Pfizer.
Photo of Anna Linton: Pharmiva